Finally, we explored the relationship between USP22 and melanoma vulnerability to ferroptosis and found that USP22 inhibition sensitizes melanoma to RSL3‐induced ferroptosis through inhibiting PI3K/Akt/mTOR pathway‐mediated SCD expression. The gene discussed is MTOR; the disease is melanoma.